Macter International Ltd
Shariah compliantA strong balance sheet and the price in an uptrend. No dividend last year and priced above its peers.
Working
- Debt is 34% of equity in the latest quarter.
- Revenue up 12% on the same quarter last year.
- Short-term assets cover short-term bills 1.8 times in the latest quarter.
To watch
- P/E 19.2 against a sector median of 11.9.
- Free cash flow negative, Rs 87m out last year, after Rs 243m the year before.
- Profit down 34% on the same quarter last year.
Keep reading MACTER: business, price trend and value
How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.
Latest results
Quarter: Jul–Sep 2026In the Jul–Sep 2026 quarter, MACTER's sales rose 12% to Rs 3.2bn, from Rs 2.9bn, and profit after tax fell 34% to Rs 95.9mn, from Rs 145.3mn (compared with Jul–Sep 2025).
Earnings per share were Rs 2.10, against Rs 3.22 a year earlier.
At Rs 262.54, MACTER trades at 15.3 times earnings.
- P/E ratio
- 15.3
- Dividend yield
- 0.0%
- Dividend payout
- 0%
- of earnings
- Return on equity
- 15%
- Net margin
- 5.0%
- last 12 months
- Debt to equity
- 0.34
MACTER quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Jul–Sep 2026 | Rs 3.2bn | Rs 95.9mn | 3.0% | Rs 2.10 | — |
| Apr–Jun 2026 | Rs 2.9bn | Rs 145.9mn | 5.0% | Rs 3.33 | — |
| Jan–Mar 2026 | Rs 2.9bn | Rs 92.5mn | 3.2% | Rs 2.01 | — |
| Oct–Dec 2025 | Rs 3.5bn | Rs 291.5mn | 8.3% | Rs 6.27 | — |
| Jul–Sep 2025 | Rs 2.9bn | Rs 145.3mn | 5.1% | Rs 3.22 | — |
| Apr–Jun 2025 | Rs 2.7bn | Rs 298.8mn | 11.1% | Rs 6.31 | Rs 2.00 |
| Jan–Mar 2025 | Rs 2.5bn | Rs 91.2mn | 3.6% | Rs 2.00 | Rs 1.80 |
| Oct–Dec 2024 | Rs 2.9bn | Rs 308.5mn | 10.7% | Rs 6.69 | — |
MACTER annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Jun 2026 | Rs 12.2bn | Rs 675.2mn | Rs 14.83 | — |
| Year to Jun 2025 | Rs 10.4bn | Rs 786.9mn | Rs 16.95 | Rs 3.80 |
| Year to Jun 2024 | Rs 8.0bn | Rs 402.2mn | Rs 8.88 | Rs 2.25 |
| Year to Jun 2023 | Rs 6.7bn | Rs 393.0mn | Rs 8.58 | Rs 1.08 |
| Year to Jun 2022 | Rs 5.3bn | Rs 318.0mn | Rs 7.18 | Rs 3.21 |
Balance sheet and price
Balance sheet as of Sep 2026- Total assets
- Rs 7.8bn
- Shareholders' equity
- Rs 4.3bn
- Cash & bank
- Rs 103.4mn
- Total debt
- Rs 1.4bn
- Current ratio
- 1.84
- 3-month high
- Rs 294.83
- 3-month low
- Rs 222.29
- 1-month change
- +6.6%
- 3-month change
- -6.0%
Read more about MACTER
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 924.15P/E 11.1
- AGPAGP LtdRs 149.85P/E 12.7
- BFBIOBF Biosciences LtdRs 123.20P/E 20.0
- CPHLCiti Pharma LtdRs 63.42P/E 15.7
- CWHCCrestwell Healthcare LimitedRs 21.35
- FEROZFerozsons Laboratories LtdRs 337.68P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 315.00P/E 10.4
- HALEONHaleon Pakistan LtdRs 658.64P/E 12.7
- HINOONHighnoon Laboratories LtdRs 956.76P/E 12.1
- HPLHoehcst Pakistan LtdRs 4056.91P/E 10.4
- IBLHLIBL HealthCare LtdRs 39.86P/E 19.1
- LIVENLiven Pharma LimitedRs 31.47
MACTER: common questions
What is MACTER's share price?
Macter International Ltd (MACTER) last closed at Rs 262.54 on the Pakistan Stock Exchange.
Does MACTER pay a dividend?
Macter International Ltd reported no dividend for the year to Jun 2026.
What were MACTER's latest results?
In the Jul–Sep 2026 quarter, MACTER's sales rose 12% to Rs 3.2bn, from Rs 2.9bn, and profit after tax fell 34% to Rs 95.9mn, from Rs 145.3mn (compared with Jul–Sep 2025).
What is MACTER's P/E ratio?
At Rs 262.54, MACTER trades at 15.3 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.

